1 results match your criteria: "University and Foundation IRCCS San Matteo[Affiliation]"
In vivo biological effects of pegfilgrastim after myelosuppressive chemotherapy in breast cancer.
Anticancer Res
November 2007
Flow Cytometry and Cell Therapy Unit, Medical Oncology, University and Foundation IRCCS San Matteo, PAVIA, Italy.
Background: No exhaustive data are available on the in vivo biological effects of pegfilgrastim utilized in dose-dense chemotherapy (CT). The cytokinetic effects exerted in a multicyclic CT program by this cytokine on CD34+/38+ peripheral blood (PB) progenitor cells was the focus of this study.
Patients And Methods: PB samples from 19 breast cancer patients treated with 4 courses of docetaxel and epirubicin followed by pegfilgrastim were studied.